Top compounds associated with response to CLDN16


Feature Type Standardized
Nominal ANOVA
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA paclitaxel gCSI pan-cancer AAC -0.24 0.0003
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.12 0.0007
mRNA Docetaxel gCSI pan-cancer AAC -0.22 0.0008
mRNA Gefitinib GDSC1000 pan-cancer AAC 0.12 0.0008
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.11 0.001
mRNA FK866 GDSC1000 pan-cancer AAC -0.1 0.001
mRNA Erlotinib gCSI pan-cancer AAC 0.22 0.002
mRNA BIBW2992 FIMM pan-cancer AAC 0.57 0.002
mRNA paclitaxel CCLE pan-cancer AAC -0.16 0.003
Download CSV